What does the progression of the Covid-19 pandemic mean for medicine-related ETFs, which hold companies such as Pfizer and BioNTech?
=
- Home
- News
- Analysis
- Investments
- Asset servicing
- Regulation
- Reports
- Events
- Media
- Funds Global
- About us
What does the progression of the Covid-19 pandemic mean for medicine-related ETFs, which hold companies such as Pfizer and BioNTech?
While Investment Grade (IG) credit fundamentals continue to look robust, central banks are wary of higher inflationary pressure. Within this environment, investors should seek an active and flexible approach.
European Ucits-regulated ETFs are gaining sales outside of Europe. Why? Because they have good ESG credentials, thanks in part to the SFDR. Our ETF roundtable discusses ESG, distribution and other topics in the ETF market.
2021 was yet another record year for the Exchange-Traded Funds industry in terms of asset levels and net flows. But what is next and can this incredible growth story continue? By Rob Rushe, senior ETF expert at CACEIS.
The worldwide trend, fuelled by energy costs and goods shortages, has strengthened fund flows towards inflation-related ETFs.
Not all sustainable ETFs are created equal. Zeb Saeed, senior product specialist at DWS Group, examines how passive approaches can assist investors in their net zero transition.
Fund oversight and compliance are crucially important features of the modern investment landscape. Our panel discussion will examine current challenges and assess why it's time to integrate, automate and digitise.
Approaching the 2030 Sustainable Development Goals midpoint, Clarity AI analysis reveals a mismatch: a $3.7T gap, urging investors to bridge it and align sectors for global progress.
